ClearPoint Neuro (CLPT) Enterprise Value (2018 - 2025)
ClearPoint Neuro (CLPT) has disclosed Enterprise Value for 13 consecutive years, with -$45.9 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 128.36% to -$45.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$45.9 million through Dec 2025, down 128.36% year-over-year, with the annual reading at -$45.9 million for FY2025, 128.36% down from the prior year.
- Enterprise Value hit -$45.9 million in Q4 2025 for ClearPoint Neuro, down from -$38.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$12.4 million in Q1 2025 to a low of -$64.9 million in Q1 2021.
- Historically, Enterprise Value has averaged -$38.2 million across 5 years, with a median of -$37.8 million in 2022.
- Biggest five-year swings in Enterprise Value: crashed 293.12% in 2021 and later skyrocketed 64.96% in 2025.
- Year by year, Enterprise Value stood at -$54.1 million in 2021, then soared by 30.68% to -$37.5 million in 2022, then skyrocketed by 38.4% to -$23.1 million in 2023, then increased by 12.99% to -$20.1 million in 2024, then crashed by 128.36% to -$45.9 million in 2025.
- Business Quant data shows Enterprise Value for CLPT at -$45.9 million in Q4 2025, -$38.2 million in Q3 2025, and -$41.5 million in Q2 2025.